I will work to strengthen guardrails and close loopholes in the Food, Drug, and Cosmetic Act to stop unapproved compounders from mass-producing risky drugs in unregulated and uninspected facilities.

Jim Banks · Indiana · Republican

policy impact 5.00 specificity 1.00 extraction confidence 95%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Occurrences

Senator Jim Banks (R-Ind.) introduced the Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act. The bill would strengthen existing guardrails and close loopholes in the Food, Drug, and Cosmetic Act to stop unapproved compounders from mass-producing risky drugs in unregulated and uninspected facilities.

Banks commits to strengthening and clarifying drug safety regulations to prevent unapproved or unsafe compounding practices.

Senator Jim Banks Introduces SAFE Drugs Act to Crack Down on Risky and Fraudulent Weight Loss Drugs
primary · press_release · model gpt-4.1

Evidence

legacy_unverified · Source version not recorded · locator unknown

This week, Senator Jim Banks (R-Ind.) introduced the Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act. The bill would strengthen existing guardrails and close loopholes in the Food, Drug, and Cosmetic Act to stop unapproved compounders from mass-producing risky drugs in unregulated and uninspected facilities.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Official Senate press release shows Banks took concrete legislative action matching the promise by introducing the SAFE Drugs Act with the stated goal of tightening FDCA guardrails on compounders.

partial same_term A for effort

Senator Jim Banks Introduces SAFE Drugs Act to Crack Down on Risky and Fraudulent Weight Loss Drugs
primary · model gpt-5.4-mini · confidence 98%

legacy_unverified · Source version not recorded · locator unknown

Sponsor: Sen. Banks, Jim [R-IN] (Introduced 02/05/2026). Latest Action: Senate - 02/05/2026 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. This bill has the status Introduced.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Congress.gov confirms the bill was introduced but had not advanced beyond referral, so the promise was not fully delivered in enacted law as of the assessment date.

never same_term A for effort

S.3794 - A bill to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, and for other purposes
secondary · model gpt-5.4-mini · confidence 99%

legacy_unverified · Source version not recorded · locator unknown

The Senate HELP Committee reported that it voted to favorably report multiple health care bills. It stated that the SAFE Drugs Act of 2026 passed as amended 17-5 and listed the SAFE Drugs Act among the approved bills.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Official committee record shows concrete progress beyond introduction: the committee approved Banks's SAFE Drugs Act as amended. This supports partial progress and a serious effort badge, but not full delivery because committee approval is not enactment.

partial same_term A for effort

Chairman Cassidy Advances Legislation Improving Families’ Access to Quality, Affordable Health Care
secondary · model gpt-5.5 · confidence 97%

unverified · Source version 61960 · locator unknown

GovInfo lists S. 3794 as the Reported in Senate version, with last action date July 27, 2026. The actions state that Banks introduced the bill, it was referred to the Senate HELP Committee, and it was reported by Senator Cassidy with an amendment. The full title is to amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Official GPO/GovInfo record confirms the bill was reported in the Senate and placed in legislative form with amendments, but it remains a reported Senate bill rather than an enacted public law. No newer enactment, passage, or reversal was found in the September 8-10, 2026 lookback search.

never same_term A for effort

S. 3794 (RS) - Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2026 - BILLS-119s3794rs | Content Details | GovInfo
secondary · model gpt-5.5 · confidence 96%

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): never. same_term A for effort

Banks made a serious same-term legislative effort by introducing the SAFE Drugs Act, and the bill advanced through Senate HELP Committee reporting as amended. However, the evidence shows it had not been enacted into law or otherwise implemented as binding federal policy by the assessment date, so the promised strengthening of FDCA guardrails and closure of loopholes was not delivered.

provider codex_cli · model gpt-5.5 · confidence 96%

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): never. same_term A for effort

Banks made a concrete same-term legislative effort by introducing S.3794, the SAFE Drugs Act, on February 5, 2026, to amend the Food, Drug, and Cosmetic Act and further regulate compounding pharmacies and outsourcing facilities. However, Congress.gov shows the bill remains only introduced and referred to the Senate HELP Committee, with no passage or enactment. Because the promised outcome was to strengthen guardrails and close loopholes, not merely introduce legislation, the outcome has not been delivered, but the effort badge is warranted.

provider codex_cli · model gpt-5.5 · confidence 96%